hCAI/II-IN-6
(Synonyms:化合物 HCAI/II-IN-6)
目录号 : KM26871
CAS No. : 694466-00-7
纯度 : 98%
hCAI/II-IN-6 is an orally active human carbonic anhydrase (CA) inhibitor. hCAI/II-IN-6 selectively inhibits hCA II and hCA VII isoforms with Ki values of 220, 4.9, 6.5 and >50000 nM for hCA I, hCA II , hCA VII and hCA XII respectively. hCAI/II-IN-6 shows anticonvulsant activity and anti maximal electroshock (MES) activity in vivo. hCAI/II-IN-6 can be used for the research of epilepsy.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
生物活性 |
hCAI/II-IN-6 is an orally active human carbonic anhydrase (CA) inhibitor. hCAI/II-IN-6 selectively inhibits hCA II and hCA VII isoforms with Ki values of 220, 4.9, 6.5 and >50000 nM for hCA I, hCA II , hCA VII and hCA XII respectively. hCAI/II-IN-6 shows anticonvulsant activity and anti maximal electroshock (MES) activity in vivo. hCAI/II-IN-6 can be used for the research of epilepsy.
|
分子式 |
C19H24N4O3S
|
分子量 |
388.48
|
CAS号 |
694466-00-7
|
中文名称 |
N-[4-(氨基磺酰基)苯基]-4-(苯基甲基)-1-哌嗪乙酰胺
|
运输条件 |
Room temperature in continental US; may vary elsewhere.
|
储存方式 |
Store at -20˚C
|